Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Schwann Cell NMDA Receptor in PNS Injury
STD and AIDS Research Training Grant
CRMP2, mitochondria, and Huntington?s disease
Collective cellular migration, cell jamming, and matrix adhesion in breast cancer model systems
Regulation of Brain Nutrients and Metals in Aging and Disease
Recently added grants:
The Role of EMT Signaling and ECM Stiffness in Cytokinetic Abscission
Retinal Degeneration Conference
Assessing Quality in Neurobehavioral Research
REhabilitation Promoting Prevention And Improved Resilience (REPPAIR)
Anticancer peptide therapeutics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35153-9-0-1
Application #
7579653
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/ University of Wisconsin Madison
$1,614,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bailey, Howard /
$1,058,141
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/
Comments
Be the first to comment on this grant